CRISPR-Cas systems have revolutionized genetic engineering, offering a precise and efficient method for genome editing.  Initially employed primarily for targeted gene disruption, recent advancements have significantly expanded its capabilities.  Base editing, a derivative technology, allows for the precise modification of single nucleotides without creating double-stranded breaks, minimizing off-target effects and expanding the scope of correctable mutations.  Prime editing, a further refinement, offers even greater flexibility, enabling all 12 possible base-to-base conversions and insertions or deletions of short sequences.  Beyond targeted modifications, CRISPR has also been leveraged for more complex applications, including gene regulation through CRISPR interference (CRISPRi) and CRISPR activation (CRISPRa), which modulate gene expression without altering DNA sequence.  Furthermore, the development of novel Cas enzymes with expanded targeting capabilities, such as Cas12 and Cas13, offers potential for broader applicability across diverse organisms and expanded therapeutic possibilities.  Ongoing research continues to address challenges such as off-target effects and efficient delivery methods, paving the way for future breakthroughs in gene therapy and agricultural biotechnology.